MEDIWOUND LTDMDWD
ASignal's systematic analysis rates MDWD as Bearish.
Reflects the latest available analysis · analyzed Oct 18, 2026
The case on MDWD
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.9)
- Low debt-to-equity ratio (0.24x)
- Positive cash position with $35.34M in total cash
- Current ratio of 2.32x indicates solid short-term liquidity
- Negative MACD histogram suggesting weakening momentum
- Price below 20-day and 50-day SMAs indicating downtrend
- Negative free cash flow (-$29.05M)
- Negative operating and net margins
- Negative YoY revenue growth (-45.80%)
- Negative EV/EBITDA (-4.11x) and unprofitable operations
See the full verdict on MDWD
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes MDWD
Most investors never get a second opinion, let alone several. ASignal runs MDWD past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.